Quay Pharma
Pharmaceutical outsourcing specialist Quay Pharma has further extended its technical expertise with the appointment of Dr. Alison Foster as project manager to establish an in-house capability for nano dispersion technology.
As co-founder and pharmaceutical programme director of IOTA NanoSolutions Ltd, Alison has over seven years’ experience in the formulation of nanoparticles of poorly soluble drugs using a proprietary technology that was promoted across Europe and the US.
Her previous roles have also encompassed project management of a variety of pharmaceutical development projects, with customers ranging from leading multinationals to small speciality companies.
Quay Pharma has an established reputation in formulation work and the development of highly effective drug delivery mechanisms for the pharmaceutical and biotech industry. The availability of nano technology within the business should further enhance the company’s formulation capabilities, particularly in expanding its portfolio of non-IP services to improve bioavailability and solubility of drugs.
“We are delighted that Alison has brought her extensive expertise to Quay Pharma,” commented CEO Maireadh Pedersen. We pride ourselves on our bespoke approach to each client project, understanding the nature of a particular drug, its properties, what needs to be achieved and devising a tailored solution. Nano dispersion technology will widen our options when it comes to the challenges of poor solubility and drug bioavailability and will provide a valuable additional benefit to all our clients.”
Quay Pharma, www.quaypharma.com.